Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| NeuroVive Pharmaceutical AB | -229,593,804 | net | 07 Feb 2025 | tx 10+180,963,542−410,557,346 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 07 Feb 2025 | SALE | NeuroVive Pharmaceutical AB | 127,448,607 | 0.45 SEK | |
| 07 Feb 2025 | SALE | NeuroVive Pharmaceutical AB | 283,108,739 | 0.45 SEK | |
| 22 Apr 2024 | PURCHASE | NeuroVive Pharmaceutical AB | 551,153 | 0.16 SEK | first after silence |
| 22 Apr 2024 | PURCHASE | NeuroVive Pharmaceutical AB | 1,215,130 | 0.16 SEK | |
| 22 Jun 2022 | PURCHASE | NeuroVive Pharmaceutical AB | 68,795,890 | 0.35 SEK | |
| 22 Jun 2022 | PURCHASE | NeuroVive Pharmaceutical AB | 31,204,110 | 0.35 SEK | first after silence |
| 30 Apr 2021 | PURCHASE | NeuroVive Pharmaceutical AB | 10,401,370 | 0.75 SEK | |
| 30 Apr 2021 | PURCHASE | NeuroVive Pharmaceutical AB | 22,931,963 | 0.75 SEK | |
| 30 Apr 2021 | PURCHASE | NeuroVive Pharmaceutical AB | 22,931,963 | 0.75 SEK |
2 purchases reported after at least 12 months of silence — most recent on 22 Apr 2024.